STRIDES (investigational drug)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STRIDES (investigational drug), covering 2024-04-24 to 2024-04-24. Get the full timeline:
Most recent: Clinical Trial Update: STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia [Phase 2, Phase 3]